Glutaredoxin2 isoform b (Glrx2b) promotes RANKL-induced osteoclastogenesis through activation of the p38-MAPK signaling pathway

BMB Reports

Volumn 45, Issue 3, 2012, Pages 171-176

  Yeon, Jeong Tae ^a,c   Choi, Sik Won ^a,c   Park, Kie In ^c   Choi, Min Kyu ^a   Kim, Jeong Joong ^a   Youn, Byung Soo ^d   Lee, Myeung Su ^b   Oh, Jaemin ^a  

^a Wonkwang University   (South Korea)

^b Wonkwang University School of Medicine   (South Korea)

^c Chonbuk National University   (South Korea)

^d AdipoGen Inc   (South Korea)

Author keywords

Glrx2b; Glutaredoxin2 isoform b; Osteoclasts; p38; Rankl

Indexed keywords

GLRX2 PROTEIN, MOUSE; GLUTAREDOXIN; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCLAST DIFFERENTIATION FACTOR; TNFSF11 PROTEIN, MOUSE;

ANIMAL; CELL CULTURE; CYTOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METABOLISM; MOUSE; OSTEOCLAST; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; GLUTAREDOXINS; ISOENZYMES; MALE; MICE; MICE, INBRED ICR; OSTEOCLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RANK LIGAND; SIGNAL TRANSDUCTION;

EID: 84861894677     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2012.45.3.171     Document Type: Article

References (23)

1. Boyle, W. J., Simonet, W. S. and Lacey, D. L. (2003) Osteoclast differentiation and activation. Nature 423, 337-342
2. Galibert, L., Tometsko, M. E., Anderson, D. M., Cosman, D. and Dougall, W. C. (1998) The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily. J. Biol. Chem. 273, 34120-34127.
3. Rao, A., Luo, C. and Hogan, P. G. (1997) Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15, 707-747.
4. Takayanagi, H. (2005) Mechanistic insight into osteoclast differentiation in osteoimmunology. J. Mol. Med. 83, 170-179.
5. Takayanagi, H. (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7, 292-304.
6. Dröge, W. (2002) Free radicals in the physiological control of cell function. Physiol. Rev. 82, 47-95
7. Lee, N. K., Choi, Y. G., Baik, J. Y., Han, S. Y., Jeong, D. W., Bae, Y. S., Kim, N. and Lee, S. Y. (2005) A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106, 852-859.
8. Fraser, J. H., Helfrich, M. H., Wallace, H. M. and Ralston, S. H. (1996) Hydrogen peroxide, but not superoxide, stimulates bone resorption in mouse calvariae. Bone 19, 223-226.
9. Kim, H., Kim, I. Y., Lee, S. Y. and Jeong, D. (2006) Bimodal actions of reactive oxygen species in the differentiation and bone-resorbing functions of osteoclasts. FEBS Lett. 580, 5661-5665.
10. Huh, Y. J., Kim, J. M., Kim, H., Song, H., So, H., Lee, S. Y., Kwon, S. B., Kim, H. J., Kim, H. H., Lee, S. H., Choi, Y., Chung, S. C., Jeong, D. W. and Min, B. M. (2006) Regulation of osteoclast differentiation by the redox-dependent modulation of nuclear import of transcription factors. Cell Death Differ. 13, 1138-1146.
11. Lean, J., Kirstein, B., Urry, Z., Chambers, T. and Fuller, K. (2004) Thioredoxin-1 mediates osteoclast stimulation by reactive oxygen species. Biochem. Biophys. Res. Commun. 321, 845-850.
12. Gallogly, M. M., Starke, D. W., Leonberg, A. K., Ospina, S. M. and Mieyal, J. J. (2008) Kinetic and mechanistic characterization and versatile catalytic properties of mammalian glutaredoxin 2: implications for intracellular roles. Biochemistry. 47, 11144-11157.
13. Enoksson, M., Fernandes, A. P., Prast, S., Lillig, C. H., Holmgren, A. and Orrenius, S. (2005) Overexpression of glutaredoxin 2 attenuates apoptosis by preventing cytochrome c release. Biochem. Biophys. Res. Commun. 327, 774-779.
14. Lillig, C. H., Lönn, M. E., Enoksson, M., Fernandes, A. P. and Holmgren, A. (2004) Short interfering RNA-mediated silencing of glutaredoxin 2 increases the sensitivity of HeLa cells toward doxorubicin and phenylarsine oxide. Proc. Natl. Acad. Sci. U.S.A. 101, 13227-13232.
15. Hudemann, C., Lönn, M. E., Godoy, J. R., Zahedi Avval, F., Capani, F., Holmgren, A. and Lillig, C. H. (2009) Identification, expression pattern, and characterization of mouse glutaredoxin 2 isoforms. Antioxid Redox Signal. 11, 1-14.
16. Theill, L. E., Boyle, W. J. and Penninger, J. M. (2002) RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu. Rev. Immunol. 20, 795-823.
17. Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J., Wagner, E. F., Mak, T. W., Kodama, T. and Taniguchi, T. (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell. 3, 889-901.
18. Kim, K., Lee, S. H., Kim, J. H., Choi, Y. and Kim, N. (2008) NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol. Endocrinol. 22, 176-185.
19. Kim, K., Kim, J. H., Lee, J., Jin, H. M., Kook, H., Kim, K. K., Lee, S. Y. and Kim, N. (2007) MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood 109, 3253-3259.
20. Huang, H., Chang, E. J., Ryu, J., Lee, Z. H., Lee, Y. and Kim, H. H. (2006) Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway. Biochem. Biophys. Res. Commun. 351, 99-105.
21. Kim, M. S., Yang, Y. M., Son, A., Tian, Y. S., Lee, S. I., Kang, S. W., Muallem, S. and Shin, D. M. (2010) RANKL-mediated reactive oxygen species pathway that induces long lasting Ca2+ oscillations essential for osteoclastogenesis. J. Biol. Chem. 285, 6913-6921.
22. Sen, C. K. (1998) Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem. Pharmacol. 55, 1747-1758.
23. Ha, H., Kwak, H. B., Lee, S. W., Jin, H. M., Kim, H. M., Kim, H. H. and Lee, Z. H. (2004) Reactive oxygen species mediate RANK signaling in osteoclasts. Exp. Cell. Res. 301,119-127.